EGR1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy is a research paper published in Experimental Hematology (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
NCI NIH HHS
Grant: P30 CA014599
NCI NIH HHS
Grant: R01 CA190372
NCI NIH HHS
Grant: R01 CA231880
NHLBI NIH HHS
Grant: R01 HL142782
National Institutes of Health
Grant: 5R01CA190372-05
Molecular mechanisms of myeloid suppressor genes on chromosome 5
National Institutes of Health
Grant: 3P30CA014599-36S1
Cancer Center Support Grant
National Institutes of Health
Grant: 5R01HL142782-02
Regulation of hematopoiesis by CUX1
National Institutes of Health
Grant: 1R01CA231880-01
The pathogenesis of chromosome 7q deletions in juvenile myelomonocytic leukemia
National Institutes of Health
American Cancer Society
American Society of Hematology
Brinson Foundation
Edward P Evans Foundation
FWCI
1.33
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals